Register for email alerts and news feeds:
This journal | BMJ Group
rss
British Journal of Ophthalmology 1998;82:856-857; doi:10.1136/bjo.82.8.856
Copyright © 1998 by the BMJ Publishing Group Ltd.
Br J Ophthalmol 1998;82:856-857 ( August )

Editorial

Serological tests for monitoring and predicting disease severity, course, and outcome of autoimmune intraocular inflammation

The first 150 words of the full text of this article appear below.

Around 50% of cases of uveitis are classified as idiopathic, while many of the others are associated with or form part of other disease entities.1 2 Idiopathic uveitis comprises a spectrum of CD4+ T cell mediated MHC class II restricted, chronic autoimmune intraocular inflammatory conditions,3 the underlying immunological effector mechanisms of which have many features in common with systemic conditions associated with intraocular inflammation---for example, sarcoidosis, Behçet's disease, seronegative spondyloarthropathies, and multiple sclerosis.4 Therapy for these conditions must be tailored to treat both ocular and systemic disease, although successful immunosuppression for the ocular inflammatory component can be achieved using the same approach as for idiopathic chronic intraocular inflammation, especially if the systemic component is inactive.5 Recognising whether intraocular inflammation is idiopathic or associated with systemic disease either at the time of presentation or in the future is difficult. For example, the term "intermediate uveitis", which includes pars planitis, not only . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis
Anne-Marie Klok, Leny Luyendijk, Michel J W Zaal, Aniki Rothova, C Erik Hack, and Aize Kijlstra
Br. J. Ophthalmol. 1998 82: 871-874. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Greiner, K., Murphy, C. C., Willermain, F., Duncan, L., Plskova, J., Hale, G., Isaacs, J. D., Forrester, J. V., Dick, A. D. (2004). Anti-TNF{alpha} Therapy Modulates the Phenotype of Peripheral Blood CD4+ T Cells in Patients with Posterior Segment Intraocular Inflammation. IOVS 45: 170-176 [Abstract] [Full Text]  
  • Kilmartin, D. J., Fletcher, Z. J., Almeida, J. A., Liversidge, J., Forrester, J. V., Dick, A. D. (2001). CD69 Expression on Peripheral CD4+ T Cells Parallels Disease Activity and Is Reduced by Mycophenolate Mofetil Therapy in Uveitis. IOVS 42: 1285-1292 [Abstract] [Full Text]  
  • Klok, A.-M., Luyendijk, L., Zaal, M. J W, Rothova, A., Kijlstra, A. (1999). Soluble ICAM-1 serum levels in patients with intermediate uveitis. Br. J. Ophthalmol. 83: 847-851 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Ophthalmology Jobs

Ophthalmology Jobs